Lower melting pharmaceutical cocrystals of Metaxalone (cas 1665-48-1) with carboxamide functionalities
-
Add time:09/07/2019 Source:sciencedirect.com
Supramolecular reactions between a muscle relaxant drug, Metaxalone (cas 1665-48-1), 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone with a few carboxamides like nicotinamide, isonicotinamide, salicylamide and carboxylic acid coformers such as 3-hydroxybenzoic acid, 4-hydroxybenzoic acid resulted binary cocrystals. The cocrystals were initially characterized by PXRD, FT˗IR, ss-NMR, DSC and finally confirmed by single crystal X-ray diffraction. Surprisingly, all the novel cocrystals exhibited melting endotherm lower than the drug and coformer, which is not so common (29%) in the literature. Vibrational spectroscopy suggests the possible stoichiometry of the drug cocrystals based on the number of carbonyl stretching frequencies and hydrate formation in case of 4-hydroxybenzoic acid cocrystal. 13C-ssNMR spectroscopy of metaxalone–salicylamide cocrystal indicates the possibility of more symmetry independent molecule of the drug in the starting material to less in the cocrystal and molecular conformation was also reflected in the spectrum. The corresponding crystal structure consists of one molecule each of metaxalone and salicylamide in the asymmetric unit. Similar to the thermodynamically stable form of the drug and cocrystals with mono/di-carboxylic acids, metaxalone forms centrosymmetric NH⋯O hydrogen bonded imide-imide homodimer in this cocrystal. Salicylamide molecules also form centrosymmetric amide-amide homosynthon. Both the homodimers are perpendicularly (79°) interlinked via bifurcated carbonyl oxygen of the drug, which results 1D chain along the crystallographic b-axis. Auxiliary C˗H⋯O interactions further stabilize the bonding between the drug and salicylamide. Binding energy calculation of metaxalone/salicylamide homodimer and metaxalone‒salicylamide heterodimer using B3LYP/6-311++G** method and in addition, the stacking energy interactions in the API suggest the most preferred API homodimer synthon in the reported polymorphs and cocrystals. The pharmaceutical cocrystals of metaxalone with amide functionalities are reported for the first time in the literature.
We also recommend Trading Suppliers and Manufacturers of Metaxalone (cas 1665-48-1). Pls Click Website Link as below: cas 1665-48-1 suppliers
Prev:A highly diastereoselective [3+3] annulation reaction of aza-oxyallyl cations and nitrones
Next:Pain management and sedation/original researchA Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone (cas 1665-48-1), Tizanidine, or Baclofen for Acute Low Back Pain) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleKinetics study of Metaxalone (cas 1665-48-1) degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method10/01/2019
- Solubilities of chlormezanone, Metaxalone (cas 1665-48-1) and methocarbamol in supercritical carbon dioxide09/27/2019
- Synthesis of poly(ethylene glycol)–Metaxalone (cas 1665-48-1) conjugates and study of its controlled release in vitro09/26/2019
- Short communicationMetaxalone (cas 1665-48-1) estimation in biological matrix using high-throughput LC–MS/MS bioanalytical method09/25/2019
- Screening and characterization of cocrystal formation of Metaxalone (cas 1665-48-1) with short-chain dicarboxylic acids induced by solvent-assisted grinding approach09/24/2019
- A fatality involving Metaxalone (cas 1665-48-1)09/10/2019
- Short CommunicationQuantitative determination of Metaxalone (cas 1665-48-1) in human plasma by LC-MS and its application in a pharmacokinetic study09/09/2019
- Pain management and sedation/original researchA Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone (cas 1665-48-1), Tizanidine, or Baclofen for Acute Low Back Pain09/08/2019